FDA Calls GSK's Avandia Safe Amid Public Concerns

Law360, New York (February 23, 2010, 2:13 PM EST) -- On the heels of senators blasting the U.S. Food and Drug Administration for its purportedly lax regulation of the GlaxoSmithKline PLC drug Avandia, the agency has published a safety announcement telling consumers they should not stop taking the diabetes medication.

The agency, which issued the announcement Monday, said it was still reviewing data from a large, long-term clinical study on possible cardiovascular risks associated with rosiglitazone — the primary component of Avandia used to treat type 2 diabetes mellitus — and will not make any new...
To view the full article, register now.